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Nonischemic Sustained Ventricular Tachycardia   Clinical Outcome in
12 Patients With Arrhythmogenic Right Ventricular Dysplasia
ROBERT LEMERY, MD, PEDRO BRUGADA, MD, JOHAN JANSSEN, MD, EMILE CHERIEX,
MD, THIERRY DUGERNIER, MD, HEIN J .J. WELLENS, MD, FACC
Maastricht, The Netherlands
The clinical course and long-term follow-up of 12 patients
with arrhythmogenic right ventricular dysplasia causing
ventricular tachycardia are presented . No patient had a
history of congestive heart failure and the cardiothoracic
ratio measured <_0 .5 in all patients . All 12 patients were
symptomatic during ventricular tachycardia ; syncope oc-
curred in 4. Exercise-related symptoms were present in 8
(73%) of 11 patients. The mean right ventricular ejection
fraction was 31% (range 20% to 54%), and the mean left
ventricular ejection fraction was 68% (range 44% to 88%) .
Signal averaging of the rest electrocardiogram (ECG) re-
vealed late potentials in five of eight patients . During
programmed electrical stimulation, sustained or nonsus-
tained ventricular tachycardia showing a left bundle
branch block configuration was induced in all patients .
One patient underwent right ventricular disconnection
Arrhythmogenic right ventricular dysplasia was first de-
scribed as a clinical entity in 1 77 by Fontaine et al . (1) and
further characterized by Marcus et al . (2) in 1 82 . The
pathologic process differs from Uhl's disease (3-13) by the
occurrence of ventricular tachycardia and the absence of
congestive heart failure (13-15) . In this study, we present the
results of noninvasive and invasive studies and long-term
follow-up in 12 patients with arrhythmogenic right ventricu-
lar dysplasia .
Methods
Study patients . The 12 patients, all men ranging in age
from 21 to 54 years, were selected from 200 patients seen
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and died I week after operation of low cardiac output
failure . The remaining 11 patients were all treated medi-
cally and are alive at a mean follow-up time of 7 .  years
after the onset of symptoms . Recurrence of symptomatic
and documented sustained monomorphic ventricular tachy-
cardia occurred in eight patients and could not be predicted
by results of long-term ECG monitoring, treadmill exercise
testing or programmed stimulation .
In conclusion, despite recurrence of ventricular tachy-
cardia, patients with arrhythmogenic right ventricular dys-
plasia have a favorable outcome when treated medically .
Noninvasive studies (imaging techniques, ambulatory ECG
monitoring and exercise testing) provide data that may be
sufficient in diagnosing arrhythmogenic right ventricular
dysplasia .
(J
Am Coil Cardiol 1 8  ;14  6`105)
since 1 77 for evaluation of nonischemic ventricular tachy-
cardia at our hospital. The diagnosis of arrhythmogenic right
ventricular dysplasia was based on the association of 1) local
or diffuse right ventricular changes during contrast angiog-
raphy (11 patients), two-dimensional echocardiography (8
patients) and nuclear angiography (4 patients); 2) sustained
monomorphic ventricular tachycardia with a left bundle
branch block configuration (all patients) ; and 3) negative T
waves in the precordial leads V, to V 3 or V4 (11 patients) . In
one patient, direct visual inspection of the heart was possible
at the time of surgery. Two-dimensional echocardiograms
were obtained on a Hewlett-Packard apparatus, and evalu-
ation of the right ventricle was mostly obtained from sub-
costal views, although all four conventional views were
always assessed . Nuclear angiograms (Ohio Nuclear Instru-
ment) were performed with the gated first pass technique .
Cardiac catheterization . Coronary angiography, which
was performed in 10 patients, revealed normal coronary
arteries in all . Left ventricular function during invasive or
noninvasive assessment revealed an ejection fraction >50%
or normal contraction in all patients . Calculation of the right
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ventricular ejection fraction at the time of angiography was
done in the anteroposterior and lateral projections during
contrast study of the right ventricle . Hemodynamic mea-
surements at the time of cardiac catheterization were ob-
tained in nine patients. Chest radiography demonstrated a
cardiothoracic ratio <_0 .5 in all patients .
Ventricular tachycardia . Sustained monomorphic ven-
tricular tachycardia was defined as ventricular tachycardia
with a well defined QRS complex with constant axis and
configuration lasting >30 s or causing loss of consciousness
and requiring intervention to be terminated . Ventricular
tachycardia was considered nonsustained when it lasted for
>3 beats but <30 s, terminating spontaneously and not
causing syncope .
Noninvasive test procedures . Graded treadmill exercise
testing with use of the Bruce protocol and 24 h ambulatory
electrocardiographic (ECG) monitoring were performed in
all patients and ventricular arrhythmias were quantified with
use of the Lown classification. The predictive value and
accuracy of noninvasive and invasive studies for predicting
recurrence of ventricular tachycardia were analyzed . A true
positive test was defined as nonsustained or sustained ven-
tricular tachycardia during testing after antiarrhythmic drug
treatment with recurrence of ventricular tachycardia . A true
negative test was defined as Lown grade 4a (or less) ventric-
ular ectopic activity during testing after antiarrhythmic drug
treatment with no recurrence of ventricular tachycardia .
Signal averaging (custom-built apparatus) of the rest
ECG obtained during sinus rhythm was performed in eight
patients according to the technique described by Simson
(15) . Filter frequencies were obtained at 40 Hz . A filtered
QRS duration of <120 ms was considered normal . A late
potential was defined as <25 µV in the last 40 ms of the
filtered QRS complex .
Programmed electrical stimulation . All patients under-
went programmed electrical stimulation of the heart, with
use of one to three bipolar or quadripolar electrode catheters
introduced percutaneously from one or both femoral veins .
Studies were performed in patients in the postabsorptive,
nonsedated state. Informed consent was obtained in all
patients, and the institutional committee on human research
approved the study protocol . All but one patient had an
electrophysiologic study in the baseline state after discon-
tinuation of all antiarrhythmic medications for >_5 half-lives .
Endocavitary electrograms (right atrium, right ventricle,
His bundle) together with ECG leads I, II, III, V
I , V4 and V 6
were recorded on a multichannel recorder at a paper speed of
100 mm/s with use of filter settings of 30 to 500 Hz for the
endocavitary electrograms. Programmed electrical stimula-
tion was performed according to previously described meth-
ods (16) with use of rectangular stimuli of 1 to 2 ms duration
with an intensity equal to twice diastolic threshold
. Ventric-
ular stimulation was performed from the right ventricular
apex in all patients, with the use of single, double and triple
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ventricular stimuli during sinus rhythm and during ventricular
pacing at 100, 120 and 140 beats/min . Two patients received
four premature ventricular stimuli   in one (Patient 5, baseline
study) sustained monomorphic ventricular tachycardia was
induced ; in the other patient (Patient 6), the tachycardia
remained noninducible. Despite stimulation from the right
ventricular outflow tract and the infusion of isoproterenol, up
to 5 µg/min (three patients) and the intravenous administra-
tion of 1 mg of atropine (one patient), these three patients
(Patients 2, 3 and 6) had only nonsustained monomorphic
ventricular tachycardia induced in the baseline study . Ven-
tricular tachycardia with a left bundle branch block config-
uration was diagnosed when the QRS complex was predom-
inantly negative in lead V, with a terminal S wave
. Electrical
alternans was considered present if a 0 .1 mV difference in
amplitude of alternate QRS and T wave complexes was seen
in all complexes in any ECG lead (17) .
Endocardial mapping of the right ventricle was per-
formed in five patients . The surface ECG and the right
ventricular apical electrogram served as reference points .
The site of origin of ventricular tachycardia was defined as
the site showing the earliest recorded electrogram before the
onset of the QRS complex . Pace-mapping of the right
ventricle was performed in one patient .
Termination of ventricular tachycardia during pro-
grammed electrical stimulation was accomplished with the
introduction of single, double and triple ventricular stimuli,
overdrive pacing or, when required, by external cardiover-
sion . Ventricular tachycardia occurring spontaneously or
during noninvasive testing was terminated either by intrav~-
nous drug administration or by external cardioversion .
Drug therapy . One patient (Patient 4) underwent serial
drug testing and Patient 2 underwent only a baseline pro-
grammed electrical stimulation study (while not receiving
antiarrhythmic drugs) . In 10 patients, the results of pro-
grammed electrical stimulation or noninvasive studies did not
modify treatment ("parallel" study) (18, 1 ) . The parallel
testing of antiarrhythmic treatment implies that the results of
noninvasive or invasive testing do not modify the selected
antiarrhythmic treatment . Only a spontaneous recurrence of
sustained ventricular tachycardia or symptomatic episodes of
nonsustained ventricular tachycardia or side effects of drug
therapy are reasons to modify antiarrhythmic treatment
(18,1 ) .
Follow-up . Long-term follow-up data were obtained in all
patients either by visit to the outpatient clinic or by contact-
ing the patient or the physician by telephone . Patient 3 has
been previously reported on (20) .
Results
Clinical and Laboratory Features (Table 1)
The mean patient age at the time of programmed electri-
cal stimulation was 33 years (range 21 to 54), and a history of
 8
	
LEMERY ET AL .
VENTRICULAR TACHYCARDIA
Table 1 . Clinical Features of 12 Patients With Arrhythmogenic Right Ventricular Dysplasia
palpitation or documented ventricular tachycardia had been
present for 1 to 14 years (mean 4 .1) . No patient had any
symptoms or signs of congestive heart failure . Mitral valve
prolapse was present in three patients including one with
associated mild mitral regurgitation . There was no familial
history of arrhythmogenic right ventricular dysplasia in any
patient, but Patient 12 has a sibling with the Wolff-
Parkinson-White syndrome and also had another sibling who
died suddenly at 13 years of age . Patients had shown
recurrences of ventricular tachycardia with a mean of 3
.4
antiarrhythmic drugs before programmed electrical stimula-
tion .
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*Systolic/diastolic . AK = akinesia ; AN = aneurysm ; C = coronary arteries ; ctr = contraction ; DEP = end-diastolic pressure   dysk = dyskinesia ; EDD =
end-diastolic diameter ; gener = generalized ; hypok = hypokinesia ; incr = increase ; inf = inferior ; IVS = interventricular septum ; LV = left ventricle ; LVEDP
= left ventricular end-diastolic pressure ; MVP = mitral valve prolapse ; N = normal ; PA = pulmonary artery ; Pt = patient number ; RA = right atrium ; RV =
right ventricle ; RVOT = right ventricular outflow tract ; TV = tricuspid valve .
Electrocardiographic features
. The most frequent abnor-
malities on the rest 12 lead ECG were T wave inversion in
the anterior precordial leads (11 of 12 patients) and in lead III
or aVF, or both (5 patients)
. Ventricular postexcitation
waves (epsilon wave) (2,3,21),
could be demonstrated on the
12 lead ECG in seven patients, including four in whom the
epsilon wave was only apparent when the V 1 precordial lead
was recorded one intercostal space higher or the gain of the
ECG was increased to double standard .
Signal averaging of the rest ECG was performed only
before antiarrhythmic drug treatment. A normal QRS dura-
tion was seen in six of eight patients, and abnormal low
Echocardiography
Hemodynamic Data (mm Hg)* Angiography M-Mode (EDD in mm)
Pt
Age
(yr) RA RV PA
LV/
LVEDP C RV LV RV LV Ratio Two-Dimensional
1 42
40 57
0.7 AN inf basal RV
; RV
incr ; LV (N)
2 26 4/I 22/6 22/8 110/7-18 N AN apex + base ;
hypok RVOT
N ctr, 34 47 0 .72
3 38 8/2 16/2 20/8 100/4 N Dilated N ctr, MVP - - - AN inf basal RV ; RV
incr ; LV
(N) ;
RVOT
dilated + hypok
4 4l - - - - N AN apex + RVOT +
anterobasal ; dilated
AK
posterobasal
5 25 5/0 20/4 20/6 125/10 N Dysk apex + RVOT ;
dilated ; hypok
gener
N ctr, MVP 30 52 0.57
6 21 4/0 28/8 28/8 160/28 - AK base   hypok
RVOT; dilated
N ctr 26
55
0.47 AN inf basal RV
;
LV (N)
7 3  2/0 16/2 16/4 120/5 N AN apex + RVOT +
base
; dilated
N ctr 60 50 1 .2
8 27 - - - - N AN inf basal ; dilated
(RVOT) hypok
gener ; staining of
dye base + under
T .V .
N ctr 32 56 0 .57 AN base, RV incr ; LV
(N) ; IVS
(paradoxical motion)
  54 4/2 16/5 12/4 140/- N AN inf basal, with
staining of dye ;
dilated ; hypok
RVOT
N ctr 40 58 0 .6  AN inf basal ; LV (N)
10 31 2/0 20/4 20/4 140/4 N AN inf basal ; RVOT
hypok ; staining of
dye   apex, dilated
N Or 37 50 0 .74 AK below TV, lateral
(mild) ; RV incr ; LV
(N)
11 33  /7 20/  20/ 110/18 N AN inf basal and N ctr 30 52 0 .58 AN inf basal, RVOT ;
10 RVOT; hypok
apex ; staining of
dye inf basal ;
dilated
MVP
12 26 6/2 15/6 1512 110/12-16 N Dysk inf basal ; hypok
RVOT
N ctr 26 52 0 .50 AN inf basal, RVOT ;
hypok RVOT ; RV
incr ; LV (N)
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amplitude in the terminal 40 ms of the QRS complex (V40)
was present in five of eight patients (15) . Ventricular tachy-
cardia recurred in four of the five patients with late poten-
tials . Ventricular tachycardia recurred in only one of three
patients without late potentials ; this recurrence followed a
decrease in dosage of the patient's antiarrhythmic drug .
Cardiac catheterization and echocardiography (Table 1)
.
Normal intracardiac pressures were seen in five patients and
an increase in rest end-diastolic pressure was seen in four
patients (right ventricle in two patients, left ventricle in two
patients) . Two patients had an increase in left ventricular
end-diastolic pressure after cineangiography
. Right ventricu-
lar angiography (performed in 11 patients) revealed dilation of
the right ventricle in  , with global or localized dysfunction in
all . Slow evacuation of dye, adjacent to poorly contractile
areas of the right ventricle, was seen in four patients . We
observed aneurysmal changes at the time of echocardiog-
raphy (Fig. 1) or angiography (Fig
. 2) in 11 patients and
dyskinetic contraction in another . The aneurysm was typi-
cally located below and adjacent to the tricuspid valve,
inferobasally in 8 of 11 patients (Fig . 1), in the anterior
infundibulum in 6 (Fig. 2) and at the right ventricular apex in
2 (Fig . 3) . The left ventricle revealed normal contraction in  
of 11 patients and regional wall abnormalities in 2 .
Characteristics of Ventricular Tachycardia
(Table 2)
Spontaneous clinical ventricular tachycardia . A history of
exercise-related ventricular tachycardia was recorded in 8
(73%) of II patients . All 12 patients were symptomatic
during ventricular tachycardia, including palpitation in 11,
syncope in 4 and fatigue and abdominal discomfort in
another. Patient 6 also had incessant ventricular tachycar-
dia. Cardioversion was required to terminate ventricular
tachycardia in 15 (7 %) of 1  documented episodes . When
all episodes of clinical ventricular tachycardia were ana-
lyzed, the mean cycle length of documented sustained mono-
morphic ventricular tachycardia was 320 ms (187 beats/min)
in the absence of antiarrhythmic drugs, compared with a
mean of 381 ms (157 beats/min) during antiarrhythmic drug
therapy (P = NS). A left bundle branch block configuration
was present in all patients. Alternans during ventricular
tachycardia was observed in six of eight tracings available
for review .
Ambulatory electrocardiographic (Holter) monitoring .
Among the 12 patients, sustained monomorphic ventricular
tachycardia was recorded in 3 (14%) of 22 Holter recordings,
and nonsustained ventricular tachycardia in 11 (50%) of 22
recordings . The positive and negative predictive values of
ambulatory monitoring (for predicting recurrence of ventric-
ular tachycardia) were, respectively, 42% and 50%, and the
predictive accuracy was 46% .
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Figure 1. Two-dimensional echocardiogram (subxiphoid view)
showing an inferobasal aneurysm (AN) of the right ventricle (RV) .
LV = left ventricle ; RA = right atrium .
Treadmill testing . Of the eight patients with exercise-
related ventricular tachycardia, treadmill testing was per-
formed in seven, and sustained monomorphic ventricular
tachycardia was provoked in four (57%) and nonsustained
ventricular tachycardia in one. Eighteen (82%) of 22 epi-
sodes of ventricular arrhythmias occurred during rather than
after exercise . The positive and negative predictive values of
exercise testing (for recurrence of ventricular tachycardia)
were, respectively, 46% and 62%, and the predictive accu-
racy was 54% .
Programmed electrical stimulation . Sustained monomor-
phic ventricular tachycardia was induced in 11 ( 2%) of the
12 patients. The tachycardia in patient 6 was noninducible in
the baseline state, with use of <_4 premature ventricular
stimuli during right ventricular pacing at 140 beats/min from
the right ventricular apex and outflow tract and with use of
an isoproterenol infusion (  55 µg/min) . Four months after
treatment with amiodarone, this patient had inducible sus-
tained monomorphic ventricular tachycardia with only one
premature ventricular stimulus . Therefore, in all patients,
the clinical episodes of ventricular tachycardia were repro-
duced by programmed electrical stimulation .
Sustained monomorphic ventricular tachycardia was in-
duced at least twice in   of 11 patients ; multiple configura-
tions of ventricular tachycardia were induced in these pa-
tients . Ventricular tachycardia had a left bundle branch
block configuration in 35 ( 0%) of 3  cases in association
with left axis deviation in 25, intermediate axis in 5 and right
axis deviation in 5 of the 35 cases . In four cases the
tachycardia had a right bundle branch block configuration ; in
these four cases, the type of tachycardia was not docu-
mented clinically, mapping was not performed and we
cannot comment precisely on the origin of the tachycardia in
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these cases. Alternans of the QRS and T wave complex (Fig .
4) could be demonstrated in 8 (32%) of 25 recordings suitable
for analysis .
The cycle length of the induced ventricular tachycardia in
the baseline state (11 patients) varied between 1 0 to 380 ms
(mean 260). compared with 220 to 600 ms (mean 334, P <
0.01) when the patient was taking oral antiarrhythmic drugs
(7 patients) . The cycle length of ventricular tachycardia
induced during programmed electrical stimulation was
shorter than that of the clinical ventricular tachycardia
because patients usually had several episodes of inducible
ventricular tachycardia with cycle lengths as short as 1 0
ms. In all but one patient, the cycle length of the ventricular
Figure 3 . Patient 4 . Right ventricular angiogram (lateral projection)
showing dilation of the right ventricle ; aneurysms are seen at the
apex (arrows) .
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Figure 2 . Patient 10 . Right ventricular angiogram (anteroposterior
projection in diastole [A] and systole [B] as well as a lateral
projection [C] are shown) . The right ventricle is dilated and less
trabecular than usual . Aneurysms are shown in the right ventricular
outflow tract (open arrows) and below the tricuspid valve (closed
arrows) .
tachycardia induced with oral antiarrhythmic drugs was at
least equal to or longer than that of the ventricular tachycar-
dia induced in the baseline state . However, in Patient   (Fig .
5), the ventricular tachycardia induced with 750 mg/day of
oral propafenone was faster, but there has been no clinical
recurrence of ventricular tachycardia after 13 months of
follow-up on that drug . The positive and negative predictive
values of programmed electrical stimulation for predicting
recurrence of ventricular tachycardia were, respectively,
55% and 0%, and the predictive accuracy was 55% .
Endocardial mapping in the right ventricle, performed
during ventricular tachycardia with a left bundle branch
block configuration in five patients, revealed the earliest site
of ventricular activation to be located in the outflow tract in
two patients, in the free wall in one patient, in the apex-free
wall junction in one patient and in the posterior and inferior
part of the right side of the septum in another patient . No
complications were noted after endocardial mapping .
Long-Term Follow-Up
The follow-up period ranges from 2 .5 to 15 years (mean
7. ) after the onset of symptoms ; and from 0 .8 to   years
(mean 4.4) after the performance of programmed electrical
stimulation . Patient 7 underwent total disconnection of the
right ventricular free wall (22), 8 months after programmed
electrical stimulation, and died I week postoperatively of
low cardiac output failure. The patient underwent surgery
because of recurrent episodes of ventricular tachycardia that
were symptomatic and required cardioversion,
JACC Vol . 14, No . I
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Table 2 . Characteristic Features of
Ventricular Tachycardia in 12 Patients With Arrhythmogenic Right Ventricular Dysplasia
A = amiodarone ; AAD = antiarrhythmic drug ; Al = alprenolol ; B = bepridil   Br = Bruce protocol ; CL = cycle length (ms)   D/A = occurrence of ventricular
arrhythmia during or after exercise ; Dil = dilantin ; Dis = disopyramide   D-S = D-sotalol   E - encainide   Ex = exercise   F = flecainide ; ISU = isoproterenol  
L = lorcainide ; Lab = labetolol ; M = metoprolol ; NSMVT = non-sustained monomorphic ventricular tachycardia ; P = palpitation   Pc = procainamide ; PES =
programmed electrical stimulation ; Pf = propafenone ; PN = propranolol ; Pt = patient number   S = sotalol ; SMVT = sustained monomorphic ventricular
tachycardia ; TMET = treadmill exercise test   VA = ventricular arrhythmias   VT = ventricular tachycardia . 0 . 1 . II . III . IVA and IVB refer to Lown grading of
ventricular arrhythmias ; the numbers under AAD are mg of drug per day .
The remaining 11 patients, treated medically, are alive (18,1 ) . In all seven, sustained monomorphic ventricular
(Table 2) . Seven of the 11 patients were discharged on tachycardia was induced during programmed electrical stim-
treatment with the same antiarrhythmic drug used at the time ulation on oral antiarrhythmic drug treatment, and they were
of programmed electrical stimulation ("parallel" study) treated with the same drug on discharge . Three of the seven
Pt
No . AAD
Clinical VT Holler
TMET PES
Event VA CL VA
Br D/A VA VT CL
1 No AAD. L - VT - - SMVT
280 to 360
A 200 P-Ex - -
0 4 - 0 -
2 No AAD, ISU Ex VT - IVB 4 A IVB NSMVT
230 to 310
A 200 VT - - -
F 400 + M 200 None
3 No AAD Ex SMVT 320 - SMVT 310
AI800+Dil150 Ex VT - D SMVT
Al 200 None - - - 4
D 111 -
4 Pc 1500 - SMVT 230 SMVT 4 D II SMVT 300 to 600
E 150, Lab 150 P
S
No AAD
VT - - - - - SMVT 200 to 250
L 300 + S 160 IVB 4 D IVB SMVT
310
S240 None - - IVB 4 D 111 -
6 No AAD, ISU Ex SMVT 440
6 D Ill NI
A - SMVT 430 SMVT - - -
SMVT
Pf 750 + M 50 P-Ex - - -
5
D IVA -
7 No AAD Ex SMVT 240 111 - - -
SMVT 220 to 270
A 400 + Dis 300 - SMVT 440 IVB - -
8
No AAD Ex SMVT 400 1
5
D SMVT SMVT 220 to 320
S 240 + A 200 - - - IVB S
D SMVT NSVT
S 240 + A 200 None - - IVA S D IVA -
 
No AAD - SMVT 400 IVB 4 D 11 SMVT 380
Pf 750 P - - IVB - - -
SMVT 220 to 320
10 No AAD Ex SMVT 250 IVA 3 D SMVT SMVT 200 to 260
B 400
- - - IVA 6 A IVB SMVT 260 to 320
B 200 - SMVT 375 - - -
B 600 None
11 No AAD Ex VT 250 SMVT 4 A
SMVT SMVT 240 to 330
B 600 - SMVT 400 111 4 A SMVT SMVT 380
Pf 450 Ex VT - IVA 4 D IVA SMVT 450
Pf  00 + Pn 220 P-Ex
12 No AAD Ex SMVT 260 IVA 5 D II SMVT 1 0 to 230
D-S 200
- SMVT - 11 - 0 SMVT 250 to 300
D-S 400 None
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Figure 4 . Patient 10 . Tracing A shows a rest 12 lead electrocardio-
gram with negative T waves in leads V, to V, III and aVF . Tracings
B and C show sustained monomorphic ventricular tachycardia
induced during programmed electrical stimulation ; alternans of the
QRS complex is seen in lead V, in tracing B and in all leads in
tracing C . The tachycardia has a left bundle branch block config-
uration .
patients have had no documented recurrence of ventricular
tachycardia, but recurrence of tachycardia has been docu-
mented in four patients, including one (Patient 10) in whom
it followed a decrease in antiarrhythmic drug dosage . All
four patients have had an event-free follow-up after increas-
ing antiarrhythmic drug dosage (two patients) or changing
antiarrhythmic drugs (two patients) .
Patient 4, who underwent serial drug testing, had induc-
ible ventricular tachycardia after five different drug trials and
had recurrence of ventricular tachycardia during follow-up .
In two of the remaining three patients who did not have a
drug study before discharge, ventricular tachycardia re-
curred during follow-up and has been controlled by modifi-
cation of antiarrhythmic drug therapy .
At last follow-up, all patients are receiving antiarrhyth-
mic drug treatment . A class I antiarrhythmic agent is being
taken by five patients, in combination with a beta-adrenergic
blocking agent in four patients and alone in another patient .
One patient is treated with a calcium channel blocking agent
(bepridil), another with a beta-blocker (alprenolol) and three
with a class III agent (amiodarone, 200 mg daily, in one and
sotalol in two others) . Beta-blockers (including sotalol)
appear to be effective in these patients ; six of seven patients
JACC Vol . 14, No . I
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treated with these agents at last follow-up have had no
recurrence of ventricular tachycardia .
Discussion
This study describes the long-term outcome of patients
with arrhythmogenic right ventricular dysplasia and pro-
vides information about the value of noninvasive and inva-
sive studies in these patients . The 12 patients studied pre-
sented with ventricular tachycardia and had no signs or
symptoms of congestive heart failure ; all had a cardiotho-
racic ratio <_0 .5. These features, typical of arrhythmogenic
right ventricular dysplasia (3,13-15), should not be consid-
ered at this point to represent mild forms or different
presentations of Uhl's disease, which is virtually always
associated with cardiomegaly and congestive heart failure
(4,13) . Although arrhythmogenic right ventricular dysplasia
may represent an early or localized form of a dilated cardio-
myopathy (23-25) or of a dilated right ventricular cardiomy-
opathy (26), no patient in our study has developed conges-
tive heart failure during a mean follow-up of 7 .  years .
Value of noninvasive studies . Holter ECG monitoring,
which usually showed nonsustained ventricular tachycardia,
and exercise testing, which showed an equal distribution of
grades of ventricular arrhythmia after antiarrhythmic drug
treatment, had a poor positive and negative predictive value
and are not helpful for assessing antiarrhythmic drug effi-
cacy. However, both Holter monitoring and exercise testing
were very important diagnostic tools . A history of palpita-
tion with documentation of ventricular tachycardia (with a
left bundle branch block configuration) during noninvasive
testing, usually in a young individual and often during
exercise testing, suggests the possibility of arrhythmogenic
right ventricular dysplasia . Further evaluation should in-
clude  1) a rest 12 lead ECG (looking for negative T waves in
the anterior precordial leads with presence of an epsilon
wave); 2) an ECG during ventricular tachycardia showing a
left bundle branch block configuration ( 0% of tracings in
our series) and electrical alternans of the QRS and T wave
complex (42% of tracings in our series compared with the
reported incidence of 26% during ventricular tachycardia
[17]) ; 3) M-mode echocardiography (27,28), showing an
increase in the right ventricle/left ventricle end-diastolic
diameter ratio (usually >0 .55), and two-dimensional echo-
cardiography, especially with subxiphoid views, which was
particularly helpful in our group of patients to localize
inferobasal aneurysms ; and 4) nuclear wall motion analysis,
which can further establish the presence of right ventricular
dysfunction. In a young patient, these features may be
sufficient to make a diagnosis of arrhythmogenic right ven-
tricular dysplasia, and neither contrast angiography nor
coronary angiography may have to be performed. However,
arrhythmogenic right ventricular dysplasia may occur at all
ages ; the oldest patient in our group is 54 years, and Suguira
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Figure 5. Patient   . The control tracing shows baseline recordings
(without antiarrhythmic drugs) . The rest 12 lead ECG during sinus
rhythm (control right) shows negative T waves in leads V, to V,, and
the other 12 lead ECG (induced ventricular tachycardia) (control
left) shows ventricular tachycardia with a left bundle branch block
configuration . a horizontal axis and a cycle length of 370 ms (162
beats/min) . During programmed electrical stimulation while the
patient was receiving 750 mg/day of oral propafenone (far right
tracing), sustained monomorphic ventricular tachycardia with a left
bundle branch block configuration was repeatedly induced, with a
cycle length varying from 260 to 320 ms (187 to 231 beats/min) . This
patient was discharged on propafenone therapy and has had no
recurrence of ventricular tachycardia during 18 months of follow-up .
et al . (2 ) described an 81 year old man in whom it was an
apparent incidental finding at autopsy .
Value of invasive studies . Ventricular tachycardia was
induced in all 12 of our patients and sustained monomorphic
ventricular tachycardia in 11 ( 2%%) . More than one type of
ventricular tachycardia was induced in   of I I patients . but
it had a left bundle branch block configuration in  0% of
episodes . The predictive accuracy of programmed electrical
stimulation was 55%%, which suggests that patients may not
have recurrence of ventricular tachycardia despite persistent
inducibility of sustained monomorphic ventricular tachycar-
dia during antiarrhythmic drug treatment . However, we
believe that electrophysiologic studies should be performed
in patients with arrhythmogenic right ventricular dysplasia .
These will allow one to 1) evaluate the substrate causing
ventricular tachycardia, reproduce the clinical ventricular
tachycardia and assess the effects of antiarrhythmic drugs   2)
evaluate the potential "vulnerability" of the right ventricle
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(in our group of patients, ventricular fibrillation was never
induced during programmed electrical stimulation) ; and 3)
localize the site or sites of ventricular tachycardia, especially
when surgery or ablation is being considered . There were no
complications during or after the electrophysiologic studies
in any patient (including the five who underwent prolonged
studies because of endocardial mapping) . The thin (but
fibrous) right ventricle of arrhythmogenic right ventricular
dysplasia appears to tolerate catheter manipulation without
sequelae . This observation is further supported by the re-
sults of ablation for ventricular tachycardia in patients with
arrhythmogenic right ventricular dysplasia (30) .
Arrhythmogenicity of arrhythmogenic right ventricular
dysplasia . Several factors support a reentrant mechanism .
During programmed electrical stimulation, predictable and
reproducible initiation and termination of ventricular tachy-
cardia have been considered to be a hallmark of reentry
(31-33). Areas of slow conduction, favoring reentry, were
demonstrated in the right ventricle of our five patients who
had endocardial mapping . Also, the finding (in five of eight
patients) of late potentials during signal averaging may also
represent areas of slow conduction and support reentry
(3,34) .
The described findings, in conjunction with published
reports of fatty infiltration, a decrease in myocardial fibers
and intramyocardial fibrosis in the dysplastic right ventricle
of patients with arrhythmogenic right ventricular dysplasia,
may cause inhomogeneity of activation and recovery, with
slow areas of conduction, and thus promote reentry . Of
interest is that 66% of our patients are controlled with
antiarrhythmic drugs that have beta-blocking properties .
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The presence of exercise-related symptoms in 73% of our
patients suggests that the autonomic nervous system may
also play an important role in the spontaneous occurrence of
ventricular tachycardia .
Long-term management of arrhythmogenic right ventricu-
lar dysplasia. In our group of patients, those who were
treated medically had a favorable outcome . Indeed, there
was a 100% survival rate in 11 patients treated medically and
followed up during a mean of 7 .  years. Furthermore,
recurrence of sustained monomorphic ventricular tachycar-
dia in our patients was not associated with sudden death and
either terminated spontaneously or was terminated by intra-
venous drugs or by external cardioversion . There have been
reports of sudden death in patients or relatives of patients
with arrhythmogenic right ventricular dysplasia (3,6,17,26,
35-38), but most of these patients either had evidence of
cardiomegaly or were not treated with antiarrhythmic drugs
at the time of death . However, Reiter et al . (35) reported on
a 13 year old girl who died suddenly while receiving quini-
dine therapy . In the study by Thierre et al . (3 ) of pathologic
changes in 12 patients with right ventricular cardiomyopa-
thy,   (75%) showed an increase in the expected heart
weight, suggestive of a more diffuse process .
Surgery for arrhythmogenic right ventricular dysplasia
has had limited success . Reported technical procedures to
control ventricular tachycardia in these patients include a
single ventriculotomy with or without cryoablation (40) and
isolation procedures of the right ventricle, either locally or
from total disconnection of the right ventricular free wall
(22,41) . In one series of 13 patients (40) there were two
deaths ; 4 patients had recurrences of ventricular tachycar-
dia, including 2 whose ventricular tachycardia was sus-
tained. In another preliminary report of 16 patients (42),
documented or probable recurrences of ventricular tachy-
cardia occurred in 8 (50%) . Also, total disconnection of the
right ventricular free wall has resulted in progressive dilation
of the right ventricle (41) and death in our only patient who
underwent surgery . Recently, Leclercq et al . (30) reported
on ablation to control ventricular tachycardia in patients
with arrhythmogenic right ventricular dysplasia . This proce-
dure could become an alternative or an adjunct to antiar-
rhythmic drug treatment in some patients with arrhyth-
mogenic right ventricular dysplasia .
Study limitations . We have presented a group of 12
patients with arrhythmogenic right ventricular dysplasia who
were referred to our hospital because of ventricular tachy-
cardia. Our findings apply to this selected group of patients .
We cannot comment on patients with clinical left ventricular
involvement, that is, ventricular tachycardia originating
from the left ventricle or left ventricular failure, or on
patients with cardiomegaly or heart failure due to right
ventricular dilation .
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